CRIS Current Research Information System

PANE, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.240
NA - Nord America 1.194
EU - Europa 1.188
AF - Africa 68
SA - Sud America 55
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.748
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.176
GB - Regno Unito 442
VN - Vietnam 431
SG - Singapore 308
CN - Cina 260
SE - Svezia 165
IT - Italia 152
HK - Hong Kong 117
DE - Germania 105
IN - India 57
CH - Svizzera 49
IE - Irlanda 49
RU - Federazione Russa 47
BR - Brasile 44
FR - Francia 42
NL - Olanda 35
JO - Giordania 22
TG - Togo 22
BG - Bulgaria 21
FI - Finlandia 21
ZA - Sudafrica 21
EE - Estonia 19
CA - Canada 13
KR - Corea 12
CI - Costa d'Avorio 11
UA - Ucraina 10
NG - Nigeria 8
PL - Polonia 7
ID - Indonesia 6
AR - Argentina 5
AT - Austria 5
GR - Grecia 5
IR - Iran 5
MY - Malesia 5
BD - Bangladesh 4
MX - Messico 4
BE - Belgio 3
EC - Ecuador 3
ES - Italia 3
TR - Turchia 3
AU - Australia 2
IQ - Iraq 2
IS - Islanda 2
JP - Giappone 2
MA - Marocco 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AZ - Azerbaigian 1
CL - Cile 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EU - Europa 1
GI - Gibilterra 1
KZ - Kazakistan 1
LB - Libano 1
MC - Monaco 1
MW - Malawi 1
NO - Norvegia 1
PA - Panama 1
PK - Pakistan 1
PY - Paraguay 1
RO - Romania 1
SC - Seychelles 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 3.748
Salva come PNG Salva come JPEG
Città #
Southend 422
Singapore 204
Chandler 173
Ashburn 150
Hong Kong 117
Ho Chi Minh City 108
Fairfield 100
Dong Ket 86
Hanoi 77
Beijing 62
Houston 54
Woodbridge 51
Seattle 50
Santa Clara 49
Bern 48
Dublin 47
Princeton 45
Wilmington 37
Ann Arbor 28
Cambridge 27
Boardman 25
Los Angeles 23
Amman 22
Lomé 22
Nanjing 22
Sofia 21
Westminster 20
Hefei 19
Padova 19
Bologna 18
Medford 17
New York 16
Dallas 13
Buffalo 12
Helsinki 12
Abidjan 11
Milan 11
Seoul 11
Shenyang 11
Ha Long 10
Thái Nguyên 10
Turin 10
Da Nang 9
Jinan 9
Quận Bình Thạnh 9
Berlin 8
Hebei 8
Saint Petersburg 8
San Diego 8
Florence 7
Haiphong 7
Vũng Tàu 7
Can Tho 6
Changsha 6
Falkenstein 6
Hải Dương 6
Redondo Beach 6
São Paulo 6
Torino 6
Toronto 6
Abeokuta 5
Biên Hòa 5
Jakarta 5
Ninh Bình 5
Quận Tân Phú 5
Redwood City 5
Rome 5
Tianjin 5
Turku 5
Warsaw 5
Bremen 4
Bắc Giang 4
Chicago 4
Guangzhou 4
Hangzhou 4
Lappeenranta 4
Mexico City 4
Munich 4
Nanchang 4
Tuy Hoa 4
Điện Bàn 4
Brussels 3
Bắc Ninh 3
Des Moines 3
Düsseldorf 3
Hyderabad 3
Jiaxing 3
London 3
Ningbo 3
Norwalk 3
Olalla 3
Phủ Lý 3
Quảng Ngãi 3
Quận Bảy 3
Serra 3
Shanghai 3
Thu Dau Mot 3
Vienna 3
Andover 2
Ankara 2
Totale 2.567
Salva come PNG Salva come JPEG
Nome #
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia 362
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study 243
BCR-ABL1 transcript detection in patients with Philadelphia-positive Acute Lymphoblastic Leukemia (ALL) using a new and high sensitive nanofluidic method 179
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib 176
The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) 171
The Bcr-Abl kinase promotes aberrant expression of spliced oncogenic Ikaros isoforms in Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with tyrosine kinase inhibitors 161
The 'Next-in-Cml' Study: A Prospective Multicenter Study of Deep Sequencing of the BCR-ABL1 Kinase Domain in Philadelphia Chromosome-Positive Patients with Non-Optimal Responses to Tyrosine Kinase Inhibitor Therapy 158
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 151
TP53 Alterations Including Missense Mutations, Aberrant Exon-Junctions and Internal Intron Retentions Are Frequent and May Contribute to MDM2 Antagonist-Resistance in B-Acute Lymphoblastic leukemia 140
Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia. 138
An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease 134
Can early switch to rituximab-bendamustine in a patient with follicular non-Hodgkin lymphoma progressing during R-CHOP be considered frontline treatment?: A case report 133
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia 131
IKZF1 (IKAROS) Deletions Are Independent On BCR-ABL1 Rearrangement and Are Associated with a Peculiar Gene Expression Signature and Poor Prognosis in Adult B-Progenitor Acute Lymphoblastic Leukemia (ALL) Patients. 131
One-Step Quantitative Molecular Approach for Detection of BCR/ABL1 Rearrangement and for Monitoring of Minimal Residual Disease in CML Patients: An Inter Laboratory Study 129
Expression of different isoforms of the B-cell mutator activation-induced cytidine deaminase (AID) in BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) Patients 129
Evaluation of Cepheid Xpert® BCR-ABL Monitor Assay in Three Italian Reference Centers for Monitoring of BCR-ABL Transcript Levels in CML Patients 128
Innovative phase I-II study of concomitant and consecutive treatment with Dasatinib and MK-0457 in refractory Ph+ CML and ALL patients 126
Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study 121
High-resolution molecular allelokaryotyping identifies novel genomic alterations in acute promyelocytic leukemia (APL) 118
High-resolution genomic profiling of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) patients identified novel recurrent copy number variations involved in both pathogenesis and resistance to tyrosine kinase inhibitors 117
Genome wide analysis of Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) reveals a recurring deletion of VPREB1 gene which affects B-cell differentiation 113
Molecular Characterization of PAX5 alterations in Adult BCR-ABL1-Positive Acute Lymphoblastic Leukemia (ALL) 104
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis 97
Impact of calreticulin mutations on treatment and survival outcomes in myelofibrosis during ruxolitinib therapy 93
null 91
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC) 53
Totale 3.827
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.032
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021341 0 0 0 0 0 27 37 37 41 30 21 148
2021/2022503 34 21 40 39 53 27 8 26 21 51 92 91
2022/2023602 48 93 19 77 37 47 19 29 120 7 47 59
2023/2024129 8 29 10 7 4 40 5 5 7 4 1 9
2024/2025584 34 59 50 38 102 25 50 26 5 56 18 121
2025/2026859 265 223 90 73 173 35 0 0 0 0 0 0
Totale 3.827